TEVA vs. TAK, ALNY, GMAB, RPRX, BGNE, BMRN, VTRS, UTHR, RDY, and SRPT
Should you be buying Teva Pharmaceutical Industries stock or one of its competitors? The main competitors of Teva Pharmaceutical Industries include Takeda Pharmaceutical (TAK), Alnylam Pharmaceuticals (ALNY), Genmab A/S (GMAB), Royalty Pharma (RPRX), BeiGene (BGNE), BioMarin Pharmaceutical (BMRN), Viatris (VTRS), United Therapeutics (UTHR), Dr. Reddy's Laboratories (RDY), and Sarepta Therapeutics (SRPT). These companies are all part of the "pharmaceutical preparations" industry.
Teva Pharmaceutical Industries (NYSE:TEVA) and Takeda Pharmaceutical (NYSE:TAK) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.
Teva Pharmaceutical Industries received 1213 more outperform votes than Takeda Pharmaceutical when rated by MarketBeat users. Likewise, 67.61% of users gave Teva Pharmaceutical Industries an outperform vote while only 56.82% of users gave Takeda Pharmaceutical an outperform vote.
Teva Pharmaceutical Industries currently has a consensus price target of $15.75, indicating a potential downside of 6.97%. Takeda Pharmaceutical has a consensus price target of $14.00, indicating a potential upside of 4.87%. Given Takeda Pharmaceutical's higher possible upside, analysts plainly believe Takeda Pharmaceutical is more favorable than Teva Pharmaceutical Industries.
Takeda Pharmaceutical has a net margin of 6.18% compared to Teva Pharmaceutical Industries' net margin of -2.88%. Teva Pharmaceutical Industries' return on equity of 37.33% beat Takeda Pharmaceutical's return on equity.
Teva Pharmaceutical Industries has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. Comparatively, Takeda Pharmaceutical has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500.
In the previous week, Teva Pharmaceutical Industries had 10 more articles in the media than Takeda Pharmaceutical. MarketBeat recorded 16 mentions for Teva Pharmaceutical Industries and 6 mentions for Takeda Pharmaceutical. Teva Pharmaceutical Industries' average media sentiment score of 0.31 beat Takeda Pharmaceutical's score of 0.27 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the media.
54.1% of Teva Pharmaceutical Industries shares are held by institutional investors. Comparatively, 9.2% of Takeda Pharmaceutical shares are held by institutional investors. 0.6% of Teva Pharmaceutical Industries shares are held by company insiders. Comparatively, 0.0% of Takeda Pharmaceutical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Takeda Pharmaceutical has higher revenue and earnings than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than Takeda Pharmaceutical, indicating that it is currently the more affordable of the two stocks.
Summary
Teva Pharmaceutical Industries beats Takeda Pharmaceutical on 10 of the 17 factors compared between the two stocks.
Get Teva Pharmaceutical Industries News Delivered to You Automatically
Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TEVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Teva Pharmaceutical Industries Competitors List
Related Companies and Tools
